Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-Controlled, Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, (MMRIIÒ) and Varicella (VARIVAXÒ) Vaccines Administered Concurrently to Healthy Children (AV018)
Brief Summary: * To compare immune responses to measles, mumps, rubella, and varicella antigens following vaccination in children who receive FluMist concurrently with MMRIIÒ and VARIVAXÒ and in children who receive an intranasal placebo mist concurrently with MMRIIÒ and VARIVAXÒ (Group 2 vs. Group 1).
* To compare immune responses to the three strains of influenza (H1N1, H3N2, and B) following a two dose regimen of FluMist in children who receive the initial FluMist dose concurrently with MMRIIÒ and VARIVAXÒ and in children who receive two doses of FluMist alone (Group 2 vs. Group 3).Secondary:
* To assess the safety and tolerability of concurrent administration of FluMist with MMRIIÒ and VARIVAXÒ.


Options:
A: Arm Label: Menhibrix A Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix B Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix C Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: ActHIB Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: ActHIB, Biological: PedvaxHIB | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: ActHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: PedvaxHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: Pediarix; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Prevnar; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: M-M-R II; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Varivax; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group
B: Arm Label: GSK1437173A _LD Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine GSK1437173A Low Dose | Arm Label: GSK1437173A _MD Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine GSK1437173A Medium Dose | Arm Label: GSK1437173A _HD Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine GSK1437173A High Dose | Arm Label: Placebo + GSK1437173A _HD Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Herpes Zoster vaccine GSK1437173A High Dose, Biological: Placebo | Arm Label: GSK1437173A_MODIFIED GROUP; Type: ACTIVE_COMPARATOR; Interventions: Biological: Herpes Zoster vaccine GSK1437173A Modified | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A Low Dose; Assigned to Arm(s): GSK1437173A _LD Group | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A Medium Dose; Assigned to Arm(s): GSK1437173A _MD Group | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A High Dose; Assigned to Arm(s): GSK1437173A _HD Group, Placebo + GSK1437173A _HD Group | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A Modified; Assigned to Arm(s): GSK1437173A_MODIFIED GROUP | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo + GSK1437173A _HD Group
C: Intervention Type: BIOLOGICAL; Name: Measles, Mumps, Rubella and Chickenpox (live vaccine); Assigned to Arm(s): N/A
D: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: FluMist | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: FluMist | Intervention Type: BIOLOGICAL; Name: FluMist; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: FluMist; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 3

Answer: D